No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs12622445 |
chr2:99440917-99440918 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs557750172 |
chr2:99440975-99440976 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs550619052 |
chr2:99440985-99440986 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs142104707 |
chr2:99441053-99441054 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs182605927 |
chr2:99441151-99441152 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs60725966 |
chr2:99441152-99441153 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs117830828 |
chr2:99441174-99441175 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs562750730 |
chr2:99441198-99441199 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs542234250 |
chr2:99441227-99441228 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs552525968 |
chr2:99441240-99441241 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs187803121 |
chr2:99441271-99441272 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs566444112 |
chr2:99441383-99441384 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs565430828 |
chr2:99441415-99441416 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs531183367 |
chr2:99441465-99441466 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs544774625 |
chr2:99441475-99441476 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs201225659 |
chr2:99441547-99441548 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs113733745 |
chr2:99441582-99441583 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs192677591 |
chr2:99441612-99441613 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs113642904 |
chr2:99441651-99441652 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs566903838 |
chr2:99441689-99441690 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs72811003 |
chr2:99441697-99441698 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs183232450 |
chr2:99441723-99441724 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs571567352 |
chr2:99441797-99441798 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs538995720 |
chr2:99441815-99441816 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs113373539 |
chr2:99441866-99441867 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs557262693 |
chr2:99441882-99441883 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs201855765 |
chr2:99441887-99441888 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs575518489 |
chr2:99441958-99441959 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs187479461 |
chr2:99442005-99442006 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs535972964 |
chr2:99442064-99442065 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs151229019 |
chr2:99442104-99442105 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs193080416 |
chr2:99442174-99442175 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs140404572 |
chr2:99442182-99442183 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs116134581 |
chr2:99442261-99442262 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs149921859 |
chr2:99442317-99442318 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs544840641 |
chr2:99442324-99442325 |
Weak transcription Enhancers Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs184840775 |
chr2:99442417-99442418 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs377073469 |
chr2:99442428-99442429 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs112106804 |
chr2:99442434-99442435 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs536490322 |
chr2:99442473-99442474 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs540767426 |
chr2:99442485-99442486 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs116262641 |
chr2:99442509-99442510 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs532538246 |
chr2:99442587-99442588 |
Weak transcription Enhancers Strong transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs72811004 |
chr2:99442588-99442589 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs573058361 |
chr2:99442687-99442688 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs571535491 |
chr2:99442702-99442703 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs189733650 |
chr2:99442724-99442725 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs145004495 |
chr2:99442753-99442754 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs192334618 |
chr2:99442773-99442774 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs183935991 |
chr2:99442822-99442823 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|